← evidence library

Evidence Library

Clinical guideline

31 sources of this kind.

• EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure European Association for the Study of the Liver · 2017-05 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 1 claim
• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis European Association for the Study of the Liver · 2018 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Nutrition in Chronic Liver Disease EASL Guideline European Association for the Study of the Liver · 2018 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis European Association for the Study of the Liver · 2010 · Tier 2
  Status not established — not checked with the publisher · unread
• EASL Clinical Practice Guidelines on the management of hepatic encephalopathy European Association for the Study of the Liver · 2022-09 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Corrigendum to 'EASL clinical practice guidelines on the management of hepatic encephalopathy' [J Hepatol 2022 (77) 807-824] European Association for the Study of the Liver · 2023 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on acute-on-chronic liver failure European Association for the Study of the Liver · 2023 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 2 claims
• EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma European Association for the Study of the Liver · 2025-02 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on liver transplantation European Association for the Study of the Liver · 2024 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines: Liver transplantation European Association for the Study of the Liver · 2016 · Tier 2
  Superseded — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on TIPS European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on vascular diseases of the liver European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on the management of autoimmune hepatitis European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on the management of hepatitis B virus infection European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL-ERN Clinical Practice Guidelines on Wilson's disease European Association for the Study of the Liver and European Reference Network · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) EASL, EASD and EASO (joint) · 2024 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Acute Liver Failure Guidelines American College of Gastroenterology · 2023-07 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• AASLD Practice Guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis American Association for the Study of Liver Diseases · 2024-06 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis American Association for the Study of Liver Diseases · 2024 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by EASL and AASLD AASLD and EASL (joint) · 2014 · Tier 2
  Status not established — not checked with the publisher · unread
• Cirrhosis in over 16s: assessment and management (NG50) National Institute for Health and Care Excellence · 2016-07-06 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 23 claims
• Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) National Institute for Health and Care Excellence · 2016-07-06 · Tier 1
  Under review — checked with the publisher on 2026-09-01 · 1 claim
• Acute upper gastrointestinal bleeding in over 16s: management (CG141) National Institute for Health and Care Excellence · 2012-06-13 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 5 claims
• Alcohol-use disorders: diagnosis and management of physical complications (CG100) National Institute for Health and Care Excellence · 2010-06-02 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 5 claims
• Guidelines on the management of ascites in cirrhosis British Society of Gastroenterology and British Association for the Study of the Liver · 2021 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 3 claims
• British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults British Society of Gastroenterology · 2024-04-16 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 6 claims
• Extracorporeal albumin dialysis for acute liver failure (HTG202, formerly IPG316) National Institute for Health and Care Excellence · 2009-09-23 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 4 claims
• Extracorporeal whole liver perfusion for acute liver failure (HTG573, formerly IPG690) National Institute for Health and Care Excellence · 2021-03-31 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 1 claim
• Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B (TA989) National Institute for Health and Care Excellence · 2024-07-24 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 2 claims
• Lumasiran for treating primary hyperoxaluria type 1 (HST25) National Institute for Health and Care Excellence · 2022-11-16 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 1 claim